Navigation Links
Lumenis(R) Presents the SlimLine(TM) GI Laser Fiber: The Latest Advancement in Laser Lithotripsy for Gastroenterology
Date:5/31/2009

CHICAGO, May 31 /PRNewswire/ -- Lumenis Ltd. announces that the first clinical series using the SlimLine GI will be presented at the Digestive Disease Week (DDW), Chicago May 30-June 4th entitled:

Holmium-YAG Laser Lithotripsy in the Treatment of Difficult Biliary Stones Utilizing Peroral Single Operator Cholangioscopy (SPYGLASS): a Multi-Center Experience.

The presentation reports on 31 patients with an average stone size of 19.3mm and impacted stones in 18 of the 31 patients. Ductal clearance was achieved in all 31 patients. (i)

The presence of stones in the gallbladder affects approximately 10% of the adult population in the United States and stones that have formed or migrated to the common bile duct affect 10%-20% of patients with gallstone disease. (ii)

Stones in the common bile duct and pancreatic duct can cause severe health complications. The procedure to diagnose and treat conditions of the biliary system including management of stones, ERCP (Endoscopic retrograde cholangiopancreatography), is performed approximately 600,000 times per year in the U.S. (iii)

Lumenis has produced the first laser fiber designed specifically for ERCP. The SlimLine GI fiber is compatible with modern cholangioscopes and when used in combination with the VersaPulse(R) PowerSuite(TM) holmium laser, the gastroenterologist can now apply the most efficient stone breaking technology available to these difficult stones in the bile and pancreatic ducts.

"The SlimLine GI has significantly changed the management of large and difficult stones in our endoscopy suite," said Dr. Sandeep Patel, Assistant Professor Digestive Disease Center, University of Texas San Antonio, and coauthor of the presentation for the DDW, " the use of laser energy to break stones has advantages that not only increase our efficiency but allow us to offer patients a less invasive solution to tr
'/>"/>

SOURCE Lumenis Ltd.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Lumenis(R) Introduces the Newest Innovations in Fractional CO2 Laser Skin Therapy
2. Lumenis(R) Seeks Shareholder Approval of Proposed Class Action Settlement
3. Lumenis(R) Introduces Four New Products & Delivery Devices at the 2008 American Academy of Ophthalmology Annual Meeting in Atlanta, Georgia USA
4. Lumenis(R) Introduces LightSheer(R) Duet(TM) for High Speed Permanent Hair Reduction
5. Lumenis(R) UltraPulse CO2 Laser to be Featured on National Television with Live Pearly Penile Papule (PPP) Procedure
6. Lumenis(R) UltraPulse CO2 Laser to be Featured on National Television with Live Pearly Penile Papules (PPP) Procedure
7. Exciting Innovation in Burn Scar Treatment Using Lumenis(R) UltraPulse(R) Laser Treatments Revealed on the Today Show
8. Updated GOLD report presents new understandings in diagnosis, treatment and prevention of COPD
9. The Art Of Maternity(TM) at Destination Maternity(R) Presents A Sacred Passage Into Motherhood; the Art of Belly Masking to Belly Casting
10. Presentation Time Correction: Keryx Biopharmaceuticals Presents at 12:00pm, ET Tomorrow (Oct. 3) at William Blair & Company Small-Cap Growth Stock Conference
11. VNUS Medical Technologies Presents at William Blair Small-Cap Growth Stock Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/18/2014)... University psychologists have made a brain-related discovery that ... disorders. , This discovery opens up the possibility ... suppress a specific brain activity that the researchers ... The Journal of Neuroscience has just ... McDonald, an associate professor of psychology and his ...
(Date:4/17/2014)... non-cancerous prostate tissue may have nearly twice the risk ... inflammation, according to results of a new study led ... , The link between persistent inflammation and cancer was ... those with a Gleason score between 7 and ... and rapidly growing prostate cancers. , "What we,ve shown ...
(Date:4/17/2014)... April issue of Experimental Biology and Medicine ... Rex Gaskins and Paul Kenis in the Institute ... the University of Illinois Urbana-Champaign describe their recent ... underlie a variety of cell functions including energy ... crucial roles in regulating normal cellular behavior, redox ...
(Date:4/17/2014)... A Northwestern University synthetic biology team has created ... create programmable therapeutics that could travel the body ... disease. , Engineering cell-based, biological devices that monitor ... in clinical synthetic biology. However, no existing technology ... a patient,s physiological state and respond in a ...
(Date:4/17/2014)... IL, April 17, 2014-- Colic affects about one in ... for numerous pediatric visits during the first several months ... colic symptoms was showing promise; however, the April 1, ... (BMJ2014;348:g2107; Sung, Valerie) reported on a study, "Probiotics and ... L reuteri for infant colic did ...
Breaking Medicine News(10 mins):Health News:Scientists discover brain's anti-distraction system 2Health News:Chronic inflammation linked to 'high-grade' prostate cancer 2Health News:Chronic inflammation linked to 'high-grade' prostate cancer 3Health News:Live cell imaging reveals distinct alterations of subcellular glutathione potentials 2Health News:Building 'smart' cell-based therapies 2Health News:New study says probiotic use for infant colic is not effective in reducing symptoms 2
... five times more lethal than other strains and has shown ... used to treat MRSA, according to a Henry Ford Hospital ... patients infected with the strain died within 30 days compared ... The average 30-day mortality rate for MRSA bloodstream ...
... receive a kidney transplant rarely develop the serious inflammatory ... a paper being presented at the American Society of ... Diego, CA. The findings indicate that having lupus should ... they need one. Individuals with the autoimmune disease ...
... A Henry Ford Hospital study found that hepatitis B does not ... is a contributing factor. The results contradict a previous ... previous hepatitis B infection. Hepatitis B is an inflammation of the ... presented at the American Association for the Study of Liver Diseases, ...
... ... Ontario health care professionals will hear firsthand from some of the ... in North America at an international conference on the diagnosis and treatment ... in the vitamin D field are presenting information that looks at the ...
... Amgen (Nasdaq: AMGN ) today announced the ... Cardiovascular Events with Aranesp® Therapy), a large, randomized, double-blind, ... kidney disease (CKD) not on dialysis, moderate anemia and ... New England Journal of Medicine and presented ...
... Oct. 30 Today Company C announced it will ... Komen for the Cure®. , On Saturday and Sunday, ... Passion for Pink event, during which 15 percent of all ... and local breast cancer awareness, research and education. A New ...
Cached Medicine News:Health News:Henry Ford Hospital study: A MRSA strain linked to high death rates 2Health News:Kidney transplants generally safe for lupus patients 2Health News:Toronto Conference Targets the Vitamin D Deficiency Crisis 2Health News:Toronto Conference Targets the Vitamin D Deficiency Crisis 3Health News:Large Study of Anemia Treatment in Chronic Kidney Disease Patients Not on Dialysis Published in the New England Journal of Medicine Failed to Meet Primary Efficacy Endpoints 2Health News:Large Study of Anemia Treatment in Chronic Kidney Disease Patients Not on Dialysis Published in the New England Journal of Medicine Failed to Meet Primary Efficacy Endpoints 3Health News:Large Study of Anemia Treatment in Chronic Kidney Disease Patients Not on Dialysis Published in the New England Journal of Medicine Failed to Meet Primary Efficacy Endpoints 4Health News:Large Study of Anemia Treatment in Chronic Kidney Disease Patients Not on Dialysis Published in the New England Journal of Medicine Failed to Meet Primary Efficacy Endpoints 5Health News:Large Study of Anemia Treatment in Chronic Kidney Disease Patients Not on Dialysis Published in the New England Journal of Medicine Failed to Meet Primary Efficacy Endpoints 6Health News:Large Study of Anemia Treatment in Chronic Kidney Disease Patients Not on Dialysis Published in the New England Journal of Medicine Failed to Meet Primary Efficacy Endpoints 7Health News:Large Study of Anemia Treatment in Chronic Kidney Disease Patients Not on Dialysis Published in the New England Journal of Medicine Failed to Meet Primary Efficacy Endpoints 8Health News:Large Study of Anemia Treatment in Chronic Kidney Disease Patients Not on Dialysis Published in the New England Journal of Medicine Failed to Meet Primary Efficacy Endpoints 9Health News:Company C Donates $40,000 To Fight Breast Cancer 2
(Date:1/15/2014)... RAPIDS, Mich. , Jan. 15, 2014 As health ... the flu virus, select Meijer pharmacies in Michigan ... strep throat to eligible patients, enabling Meijer pharmacists to administer ... strict protocol set by a physician participating in the study. ...
(Date:1/15/2014)...  Celsion Corporation (the "Company") (NASDAQ: CLSN ) ... investors to purchase an aggregate of approximately $15 million ... direct offering, led by a dedicated health care fund. ... with these investors pursuant to which the Company agreed ...
(Date:1/15/2014)... Texas , Jan. 15, 2014  Humberto C. Antunes,  ... Achievement Award" from the Journal of Drugs in ... & Clinical Conference (ODAC). The event is January 17-20, 2014, at ... Florida . The ODAC is ...
Breaking Medicine Technology:Meijer Pharmacy Offers Free Flu, Strep Testing as Influenza Cases Rise Across the Midwest 2Meijer Pharmacy Offers Free Flu, Strep Testing as Influenza Cases Rise Across the Midwest 3Celsion Corporation Announces $15 Million At-The-Market Registered Direct Offering 2Celsion Corporation Announces $15 Million At-The-Market Registered Direct Offering 3Galderma's global leader honored with a "Lifetime in Dermatology Achievement Award" by Journal of Drugs in Dermatology 2Galderma's global leader honored with a "Lifetime in Dermatology Achievement Award" by Journal of Drugs in Dermatology 3Galderma's global leader honored with a "Lifetime in Dermatology Achievement Award" by Journal of Drugs in Dermatology 4
... The Dimension Vista 1500 ... turbidemetry, nephelometry, IMT (integrated multisensor ... new design will integrate analysis ... chemistries, drugs-of-abuse, therapeutic drugs, immunosuppressive ...
... high performance portable ultrasound design provides ... echocardiography. Echocardiography (ultrasound) imaging requires ... and sensitive Doppler performance. The ... Terason's proprietary Teratech Architecture, delivers a ...
... passes through the GI tract, it transmits data ... the SmartPill Data Receiver, a small, light-weight, battery ... (supported by either a belt or lanyard). The ... measurement data, and elapsed and real time. After ...
... Endoscopic cases it is extremely popular to combine ... Light. This combination affords the surgeon optimal ... an uncomfortable pose. The Dual Light System ... System. As such the light can be ...
Medicine Products: